Cancer patients feel cold for a cluster of overlapping reasons, not just one. Anemia starves tissues of oxygen, muscle and fat loss strips away the body’s insulation and heat-generating capacity, certain chemotherapy drugs rewire how nerves sense temperature, and hormonal disruptions from treatment can quietly undermine the body’s thermostat. Because several of these forces often act at the same time in the same person, persistent coldness is one of the most common yet least discussed complaints in oncology.
Anemia and Oxygen Delivery
One of the most straightforward reasons cancer patients feel cold is anemia, a drop in red blood cells or hemoglobin that is remarkably common across cancer types. Tumors can cause anemia directly by invading bone marrow or triggering chronic inflammation that suppresses red blood cell production, and many chemotherapy regimens make it worse. When hemoglobin falls, less oxygen reaches the skin and extremities. The body responds by shunting blood toward vital organs, leaving fingers, toes, and the skin surface cooler. Cold hypersensitivity is listed among the recognized signs and symptoms of cancer-related anemia, alongside fatigue, shortness of breath, and general weakness.1Oncology. The Burden of Anaemia in Patients with Cancer
The effect can be subtle or dramatic depending on how low hemoglobin drops. Someone with mildly reduced counts might notice cold hands now and then; someone with hemoglobin in the single digits might feel persistently chilled despite wearing extra layers. Because anemia often develops gradually during treatment, many patients adapt to it psychologically and don’t mention it to their care team until it becomes severe.
Cachexia, Fat Loss, and Failing Heat Production
Cancer-associated cachexia, the progressive wasting of muscle and fat that affects a large share of people with advanced disease, strikes at the body’s ability to generate and retain heat on two fronts. Fat tissue acts as insulation; when it shrinks, heat escapes the body more easily. Muscle tissue, meanwhile, is the body’s single largest source of heat production at rest. Skeletal muscle plays a central role in thermogenesis, and reduced muscle mass is closely linked to hypothermia risk.2Endocrine Journal. Sarcopenia and body temperature—the significance of interorgan metabolic networks in skeletal muscle atrophy
Cachexia also creates a vicious metabolic cycle. The syndrome burns through energy reserves faster than the patient can replenish them through eating, which leaves less fuel available for the body to convert into warmth. Patients with advanced cancer and cachexia complain of feeling cold and are measurably more sensitive to lower ambient temperatures. The difficulty maintaining body temperature stems from this impaired thermoregulatory capacity, made worse by the calorie deficit that cachexia itself creates.3SpringerOpen. Ambient temperature modulates body weight changes in patients with advanced oncological diseases and anorexia cachexia syndrome During colder months, the added energy demand of staying warm accelerates weight loss, which further reduces heat production, creating a feedback loop that is hard to break without aggressive nutritional support.
Chemotherapy That Rewires Cold Sensation
Some chemotherapy drugs don’t just make the body colder; they change how the nervous system perceives cold in the first place. Oxaliplatin, a platinum-based drug widely used for colorectal cancer, is the most striking example. Cold hypersensitivity develops in nearly all patients receiving oxaliplatin, making even mildly cool surfaces or drinks feel painfully icy.4PubMed Central. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors The drug alters the expression of ion channels in sensory nerve fibers, essentially turning up the volume on cold-detecting neurons so that normal temperatures register as extreme cold or even pain.
In animal studies, a single dose of oxaliplatin induced cold hypersensitivity within two hours in a dose-dependent fashion, without necessarily affecting sensitivity to pressure or touch.5PubMed Central. Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice This matters because it means the patient’s core body temperature may be perfectly normal, yet cold-related discomfort is very real. People on oxaliplatin are typically warned to avoid cold drinks, ice, and even cool air on their skin during and shortly after infusions. For some patients, the sensitivity fades between treatment cycles; for others, it accumulates and lingers for months after chemotherapy ends.
Oxaliplatin gets the most attention, but other chemotherapy agents can damage peripheral nerves in ways that distort temperature sensation. Taxanes and vinca alkaloids, for example, can cause a broader peripheral neuropathy that includes altered perception of both warmth and cold. The sensation may not be as sharply cold-specific as with oxaliplatin, but it contributes to a general feeling that the body’s thermostat is off.
Raynaud’s Phenomenon From Vascular Damage
Certain chemotherapy combinations don’t just affect nerves; they damage blood vessels themselves. Raynaud’s phenomenon, in which fingers or toes turn white and numb in response to cold or stress, is a recognized vascular side effect of several cancer treatments. Cisplatin and bleomycin carry the highest risk among chemotherapy drugs, followed by beta-adrenoceptor blockers that some cancer patients also take.6PubMed Central. Drug-induced Raynaud’s phenomenon: beyond β-adrenoceptor blockers
A study of patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer found that about 44% developed Raynaud’s symptoms, and all of them showed an exaggerated blood vessel constriction response when exposed to cold. Even patients without overt finger symptoms had a greater-than-normal vasospastic response compared with healthy controls.7PubMed. Raynaud’s phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold Further investigation pointed to hyper-reactivity in the central sympathetic nervous system and impaired function in the smooth muscle cells lining small arterioles as the underlying mechanism.8Annals of Oncology. Vascular toxicity and the mechanism underlying Raynaud’s phenomenon in patients treated with cisplatin, vinblastine and bleomycin
This effect can persist long after treatment ends. Testicular cancer survivors, who are often young men cured of their disease, sometimes find themselves living with cold-triggered finger blanching and numbness for years. It’s a side effect that oncologists tend to classify as a nuisance rather than a danger, but for anyone working outdoors or in cold environments, it can meaningfully affect daily life.
Thyroid and Hormonal Disruption
Cold intolerance is one of the textbook symptoms of an underactive thyroid, and cancer treatment is a surprisingly common cause of hypothyroidism. Radiation to the head and neck, radioactive iodine therapy, and several newer targeted and immunotherapy agents can all damage or suppress the thyroid gland. Thyroid dysfunction is easily overlooked in cancer patients because fatigue, low mood, and sensitivity to cold can be chalked up to the cancer itself or to chemotherapy side effects.9PubMed Central. Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management Without routine thyroid function testing, the true cause may go undetected for months.
Hormonal therapies used in breast and prostate cancer introduce a different kind of temperature disruption. Anti-estrogen treatments in breast cancer and androgen deprivation therapy in prostate cancer can trigger vasomotor instability, the same mechanism behind menopausal hot flashes. While hot flashes get more attention, the aftermath of a flush often includes a period of chilling and shivering as the body overcorrects. The rapid cycling between heat and cold can leave patients feeling generally thermally unstable rather than consistently warm or cold. A review of treatments for these vasomotor symptoms estimated that hot flashes affect anywhere from about a quarter to over 90% of women going through natural menopause or anti-estrogen therapy.10SpringerPlus. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients Many of those patients also experience the rebound chill.
Immune Checkpoint Inhibitors and Adrenal Crisis
Newer immunotherapy drugs, particularly immune checkpoint inhibitors, have introduced an unusual route to cold intolerance. These drugs can trigger hypophysitis, an inflammation of the pituitary gland that disrupts the hormonal signals controlling the adrenal glands and thyroid. In one documented case, a patient developed sudden severe fatigue and cold intolerance just three weeks after starting combined checkpoint inhibitor therapy. His cortisol had plummeted, and he was diagnosed with hypophysitis requiring immediate steroid replacement.11Journal for ImmunoTherapy of Cancer. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
Adrenal insufficiency, meaning the body can no longer produce enough cortisol, is a well-recognized complication of checkpoint inhibitors. Cortisol helps regulate metabolism and energy use, and when it drops, the body’s ability to maintain temperature and energy levels falls with it. Because checkpoint inhibitors are now used across many cancer types, this cause of cold intolerance is becoming more common but remains under-recognized. The fix is usually straightforward once identified: hormone replacement therapy. The challenge is catching it early rather than assuming the patient is just “tired from treatment.”
Room-Temperature Fluids Dripping Into Your Veins
A more mundane but very real contributor to feeling cold during treatment is the intravenous infusion itself. Chemotherapy drugs, saline, and blood products are typically stored at room temperature or refrigerated, and when large volumes are infused into the bloodstream, they can lower core body temperature. A Cochrane review found that warmed intravenous fluids kept core temperature about half a degree higher than room-temperature fluids, and also reduced shivering.12Cochrane Database of Systematic Reviews. Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia Half a degree may not sound like much, but it’s enough to trigger discomfort and visible shivering, especially in someone already running on low reserves from anemia or cachexia.
Many infusion centers now provide heated blankets as standard practice, and some have adopted fluid-warming devices. Still, the combination of sitting still for hours, receiving cool fluids, and being in an air-conditioned clinical environment makes infusion days reliably chilly for most patients. Wearing warm layers and bringing a blanket from home are practical steps, but they address the symptom, not the mechanism.
When the Brain’s Thermostat Is Directly Affected
In rare cases, the problem sits at the top of the thermoregulatory chain. The hypothalamus, a small region at the base of the brain, is the body’s central thermostat. Tumors growing near the hypothalamus, particularly those in the sellar and suprasellar region, can theoretically disrupt temperature regulation. In practice, though, this is uncommon even when the hypothalamus is compressed, because the thermoregulatory nuclei sit on both sides of the brain and have strong compensatory capacity. Temperature dysregulation is observed more often after surgery in the area than from the tumor itself.13PubMed. Disturbances of the hypothalamic thermoregulation So while a brain tumor occasionally explains persistent cold or temperature swings, it’s far less common than the metabolic and medication-related causes described above.
When Feeling Cold Is a Warning Sign
Most of the time, feeling cold during cancer treatment is uncomfortable but not dangerous. There is one exception that deserves attention: infection in a neutropenic patient. Chemotherapy frequently suppresses white blood cells, and severe infections can develop in people whose immune systems are too depleted to mount a normal fever response. In a study of afebrile neutropenic patients with severe infections, the highest recorded temperature within 72 hours of diagnosis was 37.2°C or lower in five of nine patients. Presenting symptoms included low blood pressure, severe fatigue, shaking chills, and altered mental state, and all patients eventually deteriorated to severe sepsis or septic shock.14PubMed Central. Outcome of severe infections in afebrile neutropenic cancer patients
The practical takeaway: if you are going through chemotherapy and experience sudden, unexplained chills with shaking, especially alongside low blood pressure, confusion, or unusual fatigue, contact your oncology team immediately. The absence of fever does not rule out a life-threatening infection. In fact, the inability to generate a fever can itself be a sign that the immune system is severely suppressed. This is one scenario where “feeling cold” crosses from an annoyance into a medical emergency.
How Environmental Temperature Affects Patients in Palliative Care
For patients with advanced cancer receiving palliative care, temperature sensitivity takes on an additional dimension. The relationship between the body and its environment becomes less buffered as disease progresses. A study examining the link between environmental temperature and mortality in palliative cancer patients found that warmer ambient temperatures were associated with higher death rates, with each one-degree-Celsius increase correlating with roughly an 8% rise in mortality among patients who died in their first week of care, and about a 4% rise among those who died within a month.15BMC Palliative Care. Effects of environmental temperature on mortality in cancer patients in palliative care
This finding may seem counterintuitive for patients who report feeling cold, but it reflects the broader problem: the body’s thermoregulatory system is failing. A person with advanced cachexia and low muscle mass can’t warm up effectively in a cool room, and equally can’t cool down in a warm one. The impaired thermoregulatory capacity described earlier in the context of cachexia means these patients are vulnerable to temperature extremes in both directions. For caregivers and palliative care teams, maintaining a stable, moderate room temperature is one of the simplest interventions available, even if it doesn’t fully resolve the patient’s subjective sense of being cold.
Why Multiple Causes Hit at Once
What makes cold sensitivity so pervasive in cancer is that these mechanisms don’t wait politely in line. A person receiving oxaliplatin-based chemotherapy for colon cancer might simultaneously have anemia from the drug’s bone marrow suppression, early cachexia from reduced appetite, and subclinical hypothyroidism from an immune checkpoint inhibitor added to their regimen. Each factor alone might produce mild cold sensitivity. Together, they produce someone who feels freezing in a room that everyone else finds comfortable.
This layering effect also makes the symptom harder to treat, because no single intervention addresses all the contributing causes. Correcting anemia with transfusions helps, but won’t fix nerve damage from oxaliplatin. Thyroid hormone replacement resolves hypothyroidism-related cold intolerance, but does nothing about the muscle mass lost to cachexia. Heated blankets during infusion are comforting in the moment, but the chill from Raynaud’s phenomenon follows the patient home. Effective management usually requires identifying which causes are active in a given patient and addressing as many as possible, rather than assuming a single explanation covers it.
For patients and caregivers, the most useful thing to know may simply be this: persistent cold is not imaginary, it’s not “just part of having cancer,” and in many cases, at least some of its causes are treatable. Mentioning it to the oncology team is worth doing, because what feels like a minor comfort complaint sometimes leads to a diagnosis, whether anemia, hypothyroidism, or adrenal insufficiency, that has a straightforward fix.